Novotech nominated for Citeline Award for being excellent APAC CRO
Clinical Research | News | 0 Comment | 23 Mar, 2020
Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist in two categories for the Citelin...Read more
Avance Clinical to deliver rapid results for urgent COVID-19 trials
Clinical Research | News | 0 Comment | 20 Mar, 2020
Australian CRO Avance Clinical has said that Australia’s fast regulatory approval environment, key opinion leader ...Read more
Molecular docking show SARS-CoV-2 inhibition by Linebacker & Equivir
Clinical Research | News | 0 Comment | 18 Mar, 2020
SGX-listed Singapore eDevelopment Ltd has announced that its wholly-owned U.S. biomedical subsidiary Impact BioMedical, ...Read more
New GeoMap Tools Gets Patient Recruitment Back on Track
Clinical Research | News | 0 Comment | 11 Mar, 2020
Award-winning global leader in digital patient recruitment GeoMap Clinical by TrialWire announced on 11 March 2020 that ...Read more
Novotech Wins CRO Contract for Covid-19 Clinical Trial in South Korea
Clinical Research | News | 0 Comment | 09 Mar, 2020
Asia-Pacific’s largest specialist biotech CRO Novotech has been selected for the Komipharm International clin...Read more
WuXi Biologics congratulates Immutep on positive interim data for IMP-321
Clinical Research | News | 0 Comment | 24 Feb, 2020
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...Read more
AVROBIO announces clinical and regulatory progress for Gaucher Disease Program
Clinical Research | News | 0 Comment | 17 Jan, 2020
US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic...Read more
PPD expands clinical capabilities in China
Clinical Research | News | 0 Comment | 15 Jan, 2020
PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...Read more
Genome & Company inks clinical trial collaboration
Clinical Research | News | 0 Comment | 15 Jan, 2020
Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced th...Read more
Hummingbird Publishes Preclinical efficacy of HMBD-001 in HER3 driven Cancers
Clinical Research | News | 0 Comment | 08 Jan, 2020
Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrou...Read more
CStone initiates CS1001 trial to treat ESCC in China
Clinical Research | News | 0 Comment | 08 Jan, 2020
CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...Read more
Transgene, NEC initiate trials with AI-Powered Cancer Vaccine
Clinical Research | News | 0 Comment | 07 Jan, 2020
French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...Read more
Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019
Clinical Research | News | 0 Comment | 16 Dec, 2019
Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...Read more
Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference
Clinical Research | News | 0 Comment | 31 Dec, 2019
Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading...Read more
Roche’s Ph III cancer immunotherapy trial reveals positive results for liver cancer
Clinical Research | News | 0 Comment | 18 Dec, 2019
Liver cancer is the fourth most common cancer among men and affects approximately 24 individuals in every 100,000 people...Read more
NeuClone announces Positive Ph I results of Herceptin® (Trastuzumab) Biosimilar
Clinical Research | News | 0 Comment | 13 Dec, 2019
NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality ...Read more
Takeda presents Phase III Trial results in patients with amyloidosis
Clinical Research | News | 0 Comment | 09 Dec, 2019
Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in a...Read more
CASI Pharma gets China approval Of CNCT19 Clinical Trial Applications
Clinical Research | News | 0 Comment | 04 Dec, 2019
CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therap...Read more